Skip to content

4Accepted Sep 14, 8:56 PM ET

ANI Pharmaceuticals Sr. VP Meredith Cook Sells 500 Shares

ANIPANI PHARMACEUTICALS INC

Accepted (ET)

8:56 PM

Sep 14, 2026

Filed

Sep 14, 2026

Documents

1

Size

5.1 KB

Summary

ANI Pharmaceuticals Sr. VP Meredith Cook Sells 500 Shares

Updated

What Happened Meredith Cook, Sr. VP, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares on September 14, 2026 at $70.79 per share, for a total reported value of $35,395. The transaction is reported as a sale (S) and was effected under a pre-existing Rule 10b5-1 trading plan.

Key Details

  • Transaction date: 2026-09-14
  • Type: Sale (reported as open-market/private sale)
  • Price and value: 500 shares × $70.79 = $35,395
  • Shares owned after the transaction: not disclosed in the provided filing details
  • Footnote: Sale was made pursuant to a Rule 10b5-1 trading plan adopted by Cook on September 15, 2025
  • Timeliness: Filing and period of report are dated 2026-09-14 (no late filing indicated)

Context Sales under Rule 10b5-1 plans are pre-arranged and typically scheduled in advance, so they are often considered routine and not necessarily a change in the insider’s view of the company. For retail investors, purchases are usually more informative than routine sales; this filing documents a routine disposition under a prior trading plan rather than an ad hoc market-timing decision.

AI-written summary · check the filing